188 related articles for article (PubMed ID: 19793339)
1. Unique molecular characteristics of pediatric myxopapillary ependymoma.
Barton VN; Donson AM; Kleinschmidt-DeMasters BK; Birks DK; Handler MH; Foreman NK
Brain Pathol; 2010 May; 20(3):560-70. PubMed ID: 19793339
[TBL] [Abstract][Full Text] [Related]
2. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Feature of HOX Gene Family in the Intramedullary Spinal Tumors.
Gu S; Gu W; Shou J; Xiong J; Liu X; Sun B; Yang D; Xie R
Spine (Phila Pa 1976); 2017 Mar; 42(5):291-297. PubMed ID: 25785959
[TBL] [Abstract][Full Text] [Related]
4. Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas.
Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
[TBL] [Abstract][Full Text] [Related]
5. Myxopapillary ependymoma in children: a study of 11 cases and a comparison with the adult experience.
Cimino PJ; Agarwal A; Dehner LP
Pediatr Blood Cancer; 2014 Nov; 61(11):1969-71. PubMed ID: 25066546
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of microarray data reveals epithelial-mesenchymal-transition in pediatric ependymoma.
Ma Q; Shu C; Wang J
Anticancer Drugs; 2021 Apr; 32(4):437-447. PubMed ID: 33595943
[TBL] [Abstract][Full Text] [Related]
8. Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome.
Sasaki A; Hirato J; Hirose T; Fukuoka K; Kanemura Y; Hashimoto N; Kodama Y; Ichimura K; Sakamoto H; Nishikawa R
Brain Tumor Pathol; 2019 Apr; 36(2):92-101. PubMed ID: 30929114
[TBL] [Abstract][Full Text] [Related]
9. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of myxopapillary ependymoma.
Wang H; Zhang S; Rehman SK; Zhang Z; Li W; Makki MS; Zhou X
J Clin Neurosci; 2014 Apr; 21(4):569-73. PubMed ID: 24332590
[TBL] [Abstract][Full Text] [Related]
11. Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management.
Kraetzig T; McLaughlin L; Bilsky MH; Laufer I
J Neurosurg Spine; 2018 Feb; 28(2):201-208. PubMed ID: 29219779
[TBL] [Abstract][Full Text] [Related]
12. SOX10 Distinguishes Pilocytic and Pilomyxoid Astrocytomas From Ependymomas but Shows No Differences in Expression Level in Ependymomas From Infants Versus Older Children or Among Molecular Subgroups.
Kleinschmidt-DeMasters BK; Donson AM; Richmond AM; Pekmezci M; Tihan T; Foreman NK
J Neuropathol Exp Neurol; 2016 Apr; 75(4):295-8. PubMed ID: 26945037
[TBL] [Abstract][Full Text] [Related]
13. Unusual paediatric spinal myxopapillary ependymomas: Unique molecular entities or pathological variations on a theme?
Rogers S; Jones DTW; Ireland A; Gottardo NG; Endersby R
J Clin Neurosci; 2018 Apr; 50():144-148. PubMed ID: 29402569
[TBL] [Abstract][Full Text] [Related]
14. Spinal myxopapillary ependymomas: a retrospective clinical and immunohistochemical study.
Chen X; Li C; Che X; Chen H; Liu Z
Acta Neurochir (Wien); 2016 Jan; 158(1):101-7. PubMed ID: 26577638
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.
Ramaswamy V; Hielscher T; Mack SC; Lassaletta A; Lin T; Pajtler KW; Jones DT; Luu B; Cavalli FM; Aldape K; Remke M; Mynarek M; Rutkowski S; Gururangan S; McLendon RE; Lipp ES; Dunham C; Hukin J; Eisenstat DD; Fulton D; van Landeghem FK; Santi M; van Veelen ML; Van Meir EG; Osuka S; Fan X; Muraszko KM; Tirapelli DP; Oba-Shinjo SM; Marie SK; Carlotti CG; Lee JY; Rao AA; Giannini C; Faria CC; Nunes S; Mora J; Hamilton RL; Hauser P; Jabado N; Petrecca K; Jung S; Massimi L; Zollo M; Cinalli G; Bognár L; Klekner A; Hortobágyi T; Leary S; Ermoian RP; Olson JM; Leonard JR; Gardner C; Grajkowska WA; Chambless LB; Cain J; Eberhart CG; Ahsan S; Massimino M; Giangaspero F; Buttarelli FR; Packer RJ; Emery L; Yong WH; Soto H; Liau LM; Everson R; Grossbach A; Shalaby T; Grotzer M; Karajannis MA; Zagzag D; Wheeler H; von Hoff K; Alonso MM; Tuñon T; Schüller U; Zitterbart K; Sterba J; Chan JA; Guzman M; Elbabaa SK; Colman H; Dhall G; Fisher PG; Fouladi M; Gajjar A; Goldman S; Hwang E; Kool M; Ladha H; Vera-Bolanos E; Wani K; Lieberman F; Mikkelsen T; Omuro AM; Pollack IF; Prados M; Robins HI; Soffietti R; Wu J; Metellus P; Tabori U; Bartels U; Bouffet E; Hawkins CE; Rutka JT; Dirks P; Pfister SM; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Ellison DW; Taylor MD
J Clin Oncol; 2016 Jul; 34(21):2468-77. PubMed ID: 27269943
[TBL] [Abstract][Full Text] [Related]
16. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma.
de Almeida Magalhães T; Borges KS; de Sousa GR; Brandalise SR; Seidinger AL; Scrideli CA; Oba-Shinjo SM; Yunes JA; Tone LG
Neurol Sci; 2020 Mar; 41(3):691-694. PubMed ID: 31728854
[TBL] [Abstract][Full Text] [Related]
17. A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods.
de Sousa GR; Lira RCP; de Almeida Magalhães T; da Silva KR; Nagano LFP; Saggioro FP; Baroni M; Marie SKN; Oba-Shinjo SM; Brandelise S; de Paula Queiroz RG; Brassesco MS; Scrideli CA; Tone LG; Valera ET
J Mol Med (Berl); 2021 Aug; 99(8):1101-1113. PubMed ID: 33903940
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity within the PF-EPN-B ependymoma subgroup.
Cavalli FMG; Hübner JM; Sharma T; Luu B; Sill M; Zapotocky M; Mack SC; Witt H; Lin T; Shih DJH; Ho B; Santi M; Emery L; Hukin J; Dunham C; McLendon RE; Lipp ES; Gururangan S; Grossbach A; French P; Kros JM; van Veelen MC; Rao AAN; Giannini C; Leary S; Jung S; Faria CC; Mora J; Schüller U; Alonso MM; Chan JA; Klekner A; Chambless LB; Hwang EI; Massimino M; Eberhart CG; Karajannis MA; Lu B; Liau LM; Zollo M; Ferrucci V; Carlotti C; Tirapelli DPC; Tabori U; Bouffet E; Ryzhova M; Ellison DW; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Pfister SM; Taylor MD; Aldape K; Pajtler KW; Kool M; Ramaswamy V
Acta Neuropathol; 2018 Aug; 136(2):227-237. PubMed ID: 30019219
[TBL] [Abstract][Full Text] [Related]
20. Expression and Clinical Significance of Translation Regulatory Long Non-Coding RNA 1 (TRERNA1) in Ependymomas.
Malgulwar PB; Nambirajan A; Singh M; Suri V; Sarkar C; Sharma MC
Pathol Oncol Res; 2020 Jul; 26(3):1975-1981. PubMed ID: 31489574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]